Phillips-Medisize completes Medicom acquisition, announces Compamed plans

Major drug delivery player Phillips-Medisize has announced the completion of the acquisition of Medicom Innovation Partner of Denmark, including its subsidiary in Cambridge, UK.

Medicom, which specialises in connected health drug delivery devices has grown continuously and employs a staff of 90 specialists in Denmark and the UK.

This means that Phillips-Medisize now employs about 500 engineers throughout its global design and development network with hubs in Struer, Denmark and Hudson, WI, USA to develop injectable and inhalation devices for the global market.

The firm has also hinted at its plans for the Compamed show in Dusseldorf, Germany, later this year.

The variety of contract services featured on the group’s stand includes device strategy, product development and manufacture across specialty drug delivery devices, dosing systems, disposables and consumables for diagnose components, disposable insulin pens, blood glucose meters, inhalators, multi-component dosing units, spray applicators, IV sets, peristaltic pumps, titration plates, mixing injectors, right up to complete MDD application sets.

The group will also be showing its work in the field of wearable drug delivery devices, which come with considerable benefits in insulin dosing and delivery.